NIPH Stock Overview
EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
EI- Nile Co. for Pharmaceuticals and Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م80.16 |
| 52 Week High | ج.م103.99 |
| 52 Week Low | ج.م34.42 |
| Beta | 0.16 |
| 1 Month Change | 4.09% |
| 3 Month Change | 1.91% |
| 1 Year Change | 102.17% |
| 3 Year Change | 126.70% |
| 5 Year Change | 241.98% |
| Change since IPO | 436.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| NIPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | -2.0% | 0.8% | -1.0% |
| 1Y | 102.2% | 32.1% | 60.7% |
Return vs Industry: NIPH exceeded the EG Pharmaceuticals industry which returned 35.9% over the past year.
Return vs Market: NIPH exceeded the EG Market which returned 67.8% over the past year.
Price Volatility
| NIPH volatility | |
|---|---|
| NIPH Average Weekly Movement | 5.6% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in EG Market | 13.3% |
| 10% least volatile stocks in EG Market | 4.8% |
Stable Share Price: NIPH has not had significant price volatility in the past 3 months.
Volatility Over Time: NIPH's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | n/a | Khaled Salah Hagag | www.nilepharma.com.eg |
EI- Nile Co. for Pharmaceuticals and Chemical Industries develops, produces, and sells pharmaceutical products in Egypt. The company offers tablets, capsules, ampoules, powders, gels and creams, syrups, suppositories, lotions, shampoos, ointments, mouthwashes, powder solutions, and nasal and midodrine drops. It also exports its products to the countries in the Middle East.
EI- Nile Co. for Pharmaceuticals and Chemical Industries Fundamentals Summary
| NIPH fundamental statistics | |
|---|---|
| Market cap | ج.م811.62m |
| Earnings (TTM) | ج.م94.03m |
| Revenue (TTM) | ج.م936.31m |
8.6x
P/E Ratio0.9x
P/S RatioIs NIPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NIPH income statement (TTM) | |
|---|---|
| Revenue | ج.م936.31m |
| Cost of Revenue | ج.م699.81m |
| Gross Profit | ج.م236.50m |
| Other Expenses | ج.م142.47m |
| Earnings | ج.م94.03m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.29 |
| Gross Margin | 25.26% |
| Net Profit Margin | 10.04% |
| Debt/Equity Ratio | 70.1% |
How did NIPH perform over the long term?
See historical performance and comparison